Drug(薬物リスト) DrugBank | All Description Patterns

e.g. "Sirolimus", "アダリムマブ"

ABCDEFGH I JKLMNOPQRSTUVWXYZother

72 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG
💬 Info on mouse-over
KEGG GENES
💬 Info on mouse-over
KEGG PATHWAY 指定難病告示番号
💬 Info on mouse-over
1 Acetate Acetate - - - 43件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
2 Alx-0081 - - - - 1件: 64 💬
3 Anfibatide Anfibatide - - - 1件: 64 💬
4 Anti-von willebrand factor nanobody Von Willebrand Factor Human - - - 1件: 64 💬
5 Anti-von willebrand factor nanobody, caplacizumab Caplacizumab 1件: D11160 💬 1件: VWF 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 1件: 64 💬
6 Anti-von willebrand factor nanobody, inn = caplacizumab Caplacizumab 1件: D11160 💬 1件: VWF 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 1件: 64 💬
7 Apadamtase alfa Apadamtase alfa - - - 1件: 64 💬
8 Apademtase alfa - - - - 1件: 64 💬
9 Arc 1779 - - - - 2件: 64, 288 💬
10 Arc1779 - - - - 2件: 64, 288 💬
11 Arc1779 injection - - - - 2件: 64, 288 💬
12 Bax930 - - - - 1件: 64 💬
13 Bax930 - recombinant human adamts13 - - - - 1件: 64 💬
14 Bax930 or shp655 - - - - 1件: 64 💬
15 Cablivi - - - - 1件: 64 💬
16 Caplacizumab Caplacizumab 1件: D11160 💬 1件: VWF 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 1件: 64 💬
17 Caplacizumab (alx-0081) Caplacizumab 1件: D11160 💬 1件: VWF 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 1件: 64 💬
18 Caplacizumab (an anti-von willebrand factor nanobody alx-0081) Caplacizumab 1件: D11160 💬 1件: VWF 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 1件: 64 💬
19 Caplacizumab (an anti-von willebrand factor nanobody) Caplacizumab 1件: D11160 💬 1件: VWF 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 1件: 64 💬
20 Corticosteroid treatment (methylprednisolone or prednisolone) Methylprednisolone 14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 64 💬
21 Corticosteroids - - - - 10件: 41, 46, 49, 64, 97, 107, 164, 220, 296, 300 💬
22 Cryosupernatant plasma - - - - 1件: 64 💬
23 Cyclosporine Cyclosporine 1件: D00184 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬
24 Danazol Danazol 1件: D00289 💬 3件: AR, ESR1, PGR 💬 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 5件: 60, 63, 64, 65, 285 💬
25 Desmopressin Desmopressin 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 5件: 6, 64, 72, 225, 288 💬
26 Desmopressin acetate Acetate 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 2件: 64, 288 💬
27 Dexamethasone Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
28 Hmed-ides Imlifidase 1件: D11470 💬 - - 2件: 64, 221 💬
29 Idec-c2b8, ro 45-2294 - - - - 1件: 64 💬
30 Ides Imlifidase 1件: D11470 💬 - - 2件: 64, 221 💬
31 Ides (0.25 mg/kg) Imlifidase 1件: D11470 💬 - - 1件: 64 💬
32 Ides (0.50 mg/kg) Imlifidase 1件: D11470 💬 - - 1件: 64 💬
33 Immunosuppressive treatment (eg, rituximab) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 64 💬
34 Mabthera - - - - 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬
35 Magnesium Magnesium - - - 16件: 6, 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬
36 Masp-2 antibody Narsoplimab 1件: D11531 💬 1件: MASP2 💬 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 2件: 64, 109 💬
37 Methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 44件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
38 Minirin - - - - 2件: 64, 288 💬
39 Octaplas - - - - 1件: 64 💬
40 Octaplas infusion - - - - 1件: 64 💬
41 Octaplas sd - - - - 1件: 64 💬
42 Octaplaslg® - - - - 1件: 64 💬
43 Octaplas®lg - - - - 1件: 64 💬
44 Octostim - - - - 2件: 64, 288 💬
45 Oms721 - - - - 3件: 64, 66, 109 💬
46 Oms721 100 mg/ml injection solution, oms00620646, oms620646, masp-2 antibody Narsoplimab 1件: D11531 💬 1件: MASP2 💬 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 2件: 64, 109 💬
47 Oms721 185 mg/ml injection solution, oms00620646, oms620646, masp-2 antibody Narsoplimab 1件: D11531 💬 1件: MASP2 💬 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 2件: 64, 109 💬
48 Other: standard of care - - - - 7件: 13, 49, 64, 85, 96, 245, 246 💬
49 Plasma exchange (pe) - - - - 1件: 64 💬
50 Pooled plasma (human), solvent/detergent treated - - - - 1件: 64 💬
51 Prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
52 Prednisone Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 47件: 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
53 Procedure: plasma exchange - - - - 5件: 13, 43, 44, 64, 222 💬
54 Radamts-13 - - - - 1件: 64 💬
55 Recombinant a disintegrin and metalloproteinase thrombospondin type-1 motifs 13 - - - - 1件: 64 💬
56 Recombinant a disintegrin and metalloproteinase with thrombospondin type-1 - - - - 1件: 64 💬
57 Recombinant a disintegrin and metalloproteinase with thrombospondin type-1 motifs - - - - 1件: 64 💬
58 Recombinant a disintegrin and metalloproteinase with thrombospondin type-1 motifs 13 - - - - 1件: 64 💬
59 Recombinant a disintegrin and metalloproteinase with thrombospondin type-1 motifs 13 (radamts13) - - - - 1件: 64 💬
60 Recombinant adamts13 - - - - 1件: 64 💬
61 Rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
62 Romiplostim Romiplostim 1件: D08990 💬 1件: MPL 💬 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 4件: 60, 63, 64, 65 💬
63 Shp 655 (bax 930) - - - - 1件: 64 💬
64 Shp655 - - - - 1件: 64 💬
65 Standard of care - - - - 12件: 6, 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬
66 Standard plasma - - - - 1件: 64 💬
67 Standrd of care treatment - - - - 1件: 64 💬
68 Sulfate Sulfate ion - - - 25件: 2, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬
69 Sulfate, magnesium Magnesium - - - 1件: 64 💬
70 Tak-755 orbax930 or shp655 - - - - 1件: 64 💬
71 Uniplas - - - - 1件: 64 💬
72 Von willebrand factor Von Willebrand Factor Human - - - 2件: 64, 288 💬

先頭へ